Sentence examples for during transdermal from inspiring English sources
Even though curcumin has shown a remarkable efficacy in the treatment of psoriasis, its effective penetration through the stratum corneum is still a major challenge during transdermal delivery.
This study was undertaken to determine the maternal and fetal steady-state concentrations of glyceryl trinitrate (GTN) and its dinitrate metabolites during transdermal administration, at the time of fetal blood sampling for obstetric indications.
These drugs must be chemically stable during patch storage and during transdermal diffusion when the patch is on the patient's body.
Reductions in baseline scores for the ADHD-AM-RS (ADHD-RS evaluated between 6.00 am and 9.00 am) were greater during MTS treatment (67%reductionon vs. baseline) than during placebo transdermal treatment (25 % reduction vs. baseline; p = 0.003 for MTS vs. placebo).
This study was designed to assess the effect of oral L-arginine on the development of tolerance during continuous transdermal nitroglycerin (TD-GTN) therapy.
Similar metabolic profiles were produced during the transdermal metabolism of FPM and FPMH in previously frozen rat skin, indicating the robust nature of the esterase enzymes involved.
The present study was designed to study the impact of intermittent hemodialysis on the disposition of the partial agonist buprenorphine and its metabolite norbuprenorphine during therapy with transdermal buprenorphine in chronic pain patients with end-stage kidney disease.
The most common form of NRT used during pregnancy was transdermal patches (65% of all prescriptions), followed by inhalator cartridges (17%), gum (8%), lozenges (6%), sublingual tablets (2%), oromucosal spray (0.7%), and nasal spray (0.3%).
Patch adhesion was also evaluated systematically every 48 hours during the time of transdermal treatment.
43 Despite the higher incidence of rash and pruritus in the transdermal group during the present study, caregivers preferred the transdermal route.
Total control and complete control were achieved by 43.7% and 48.3% of patients, respectively, during acute phase in the transdermal granisteron arm, compared with 52.4% and 59.5% in the oral granisetron arm (not statistically significant).
